Seremig Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info

Concise Prescribing Info

Contents

Flunarizine diHCl

Indications/Uses

Migraine prophylaxis. Treatment & prevention of disturbances in the vestibule, cerebral & peripheral circulatory system eg, dizziness, tinnitus, vertigo, lack of conc, confusion, memory disturbances, sleep rhythm disorders, irritability, convulsion, paresthesia, cold sensation of extremities, trophic disorders.

Dosage/Direction for Use

Initial dose: Elderly >65 yr 5 mg/day, <65 yr 10 mg/day (as night doses). Maintenance: 5 days treatment/wk & 2 successive drug-free days. Max:10 mg/day. Duration of treatment: Chronic vertigo: >1 mth. Paroxysmal vertigo: 2 mth.

Administration

May be taken with or without food.

Contraindications

History of depression or Parkinson's disease & other extrapyramidal disorders. Pregnancy.

Special Precautions

Hypotension. May impair ability to drive or operate machinery. Kidney failure. Pregnancy & lactation. Childn.

Adverse Reactions

Drowsiness, fatigue, extrapyramidal reactions (bradykinesia, rigidity, akathisia, dyskinesia, tremor especially in the elderly, epigastric pain, nausea, gastralgia, insomnia, anxiety, galactorrhea, dry mouth, muscle pain, skin rash.

View ADR Monitoring Form

Drug Interactions

β-blockers.

MIMS Class

Peripheral Vasodilators & Cerebral Activators / Antimigraine Preparations

ATC Classification

N07CA03 - flunarizine ; Belongs to the class of antivertigo preparations.

Regulatory Classification

Presentation/Packing

Form

Seremig caplet 10 mg

Packing/Price

5 × 10's

Seremig

flunarizine

Manufacturer:

Ifars